Cargando…
The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis
With its identification as a proto-oncogene in chronic lymphocytic leukaemia and central role in regulating NF-κB signalling, it is perhaps not surprising that there have been an increasing number of studies in recent years investigating the role of BCL-3 (B-Cell Chronic Lymphocytic Leukaemia/Lympho...
Autores principales: | Legge, Danny N, Chambers, Adam C, Parker, Christopher T, Timms, Penny, Collard, Tracey J, Williams, Ann C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221501/ https://www.ncbi.nlm.nih.gov/pubmed/31930327 http://dx.doi.org/10.1093/carcin/bgaa003 |
Ejemplares similares
-
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
por: Hoskin, Ashley J., et al.
Publicado: (2023) -
BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells
por: Legge, Danny N., et al.
Publicado: (2019) -
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination
por: Parker, Christopher, et al.
Publicado: (2022) -
BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling
por: Urban, Bettina C, et al.
Publicado: (2016) -
5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis
por: Dixon, Steven William, et al.
Publicado: (2021)